Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.Market Watch • 09/05/26
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/04/26
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?Zacks Investment Research • 09/02/26
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B DealZacks Investment Research • 09/01/26
Insurers Are Pulling Back From GLP-1 Drugs. The FDA Just Handed Eli Lilly Its Best Weapon Yet24/7 Wall Street • 09/01/26
Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.The Motley Fool • 08/31/26
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakersCNBC • 08/31/26
Eli Lilly to buy Merida Biosciences for up to $2.88B, expanding immunology pipelineProactive Investors • 08/31/26
LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in DiabetesZacks Investment Research • 08/31/26
Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock.Barrons • 08/31/26